Do glucosamine and chondroitin work? What the evidence shows

The evidence is mixed. Large trials of glucosamine and chondroitin for knee osteoarthritis have produced inconsistent results, and major guidelines disagree about whether they are worth taking at all. If you buy one anyway, the dose on the label matters, because the studies used specific amounts.

This guide covers what the best-known trial actually tested, what the US National Center for Complementary and Integrative Health (NCCIH) says today, and how to check a joint supplement label against those numbers before you pay.

What does the research say about glucosamine and chondroitin?

NCCIH, part of the National Institutes of Health, summarizes it plainly: studies of glucosamine and chondroitin for knee osteoarthritis have had inconsistent results, and expert evaluations have reached conflicting conclusions. It calls it "still uncertain" whether they help knee symptoms.

The same page gives some detail. A 2018 combined analysis of 29 studies (6,120 participants) found that global pain was reduced by glucosamine or chondroitin taken separately, but not by the two combined. A 2019 analysis of 18 chondroitin studies found a benefit with much inconsistency between studies. When only the low-risk-of-bias studies were kept, a specific pharmaceutical-grade preparation stood out from other brands.

That last point is easy to miss. Results that look good often come from one particular product, sometimes a prescription-grade one sold in Europe, not from the capsules on a US shelf.

What happened in the GAIT trial?

The Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) is the study most joint offers lean on, so it is worth knowing what it found. It was a double-blind, placebo- and celecoxib-controlled trial that assigned 1,583 people with painful knee osteoarthritis to one of five groups for 24 weeks: 1,500 mg of glucosamine daily, 1,200 mg of chondroitin sulfate daily, both together, 200 mg of celecoxib daily, or placebo.

The main result was disappointing for the supplements. The primary outcome was a 20 percent drop in knee pain. In the placebo group, 60.1 percent of people reached it. Glucosamine was 3.9 percentage points higher, chondroitin 5.3 points higher and the combination 6.5 points higher, and none of those gaps was statistically significant. The celecoxib group was 10.0 points above placebo, which was significant.

There was one subgroup finding. Among the 354 people with moderate-to-severe pain at the start, 79.2 percent responded to the combination versus 54.3 percent on placebo. A subgroup result from a trial that missed its main goal is a lead for further research, not proof.

A 24-month follow-up from the same trial looked at joint structure in 572 people. No treatment group showed a statistically significant difference in joint space loss versus placebo, and the authors noted the study had limited power for that question. NCCIH reports that a separate Australian two-year trial found less joint space narrowing with the combination, so the structural question is also unsettled.

Do the guidelines agree?

No. According to NCCIH, the 2019 American College of Rheumatology and Arthritis Foundation guideline strongly recommends against glucosamine and chondroitin, alone or together, for knee osteoarthritis, saying the best data do not show any important benefit. The 2019 OARSI guideline also strongly recommends against both. By contrast, the 2021 American Academy of Orthopaedic Surgeons guideline lists both among supplements that may help mild-to-moderate knee osteoarthritis, while cautioning that the evidence is inconsistent. The European ESCEO statement backs prescription crystalline glucosamine sulfate and prescription chondroitin sulfate but discourages other formulations.

If experts who read the same studies disagree, a sales page that says the research "proves" a formula is overstating. Our review method shows how we test that wording against the actual studies.

How do label doses compare with the trial doses?

The trial amounts are the yardstick. GAIT used 1,500 mg of glucosamine and 1,200 mg of chondroitin sulfate a day. Now compare a few offers we have reviewed.

• Joint Glide lists 200 mg of glucosamine hydrochloride per serving. Our review notes that this falls well short of the 1,000 mg-plus amounts used in most clinical trials.
• Advanced Collagen Plus lists 10 mg of chondroitin sulfate. Our review calls it a token amount, far below research doses.
• Joint Eternal names glucosamine sulfate and chondroitin sulfate but publishes no amount for either.
• MoveWell Daily also names glucosamine sulfate and chondroitin sulfate with no milligram amounts.

A named ingredient with a hidden dose tells you nothing. A named ingredient at 10 mg or 200 mg is not the thing the studies tested. Only a label that prints the amount lets you do this arithmetic, which is why our reviews compare every printed dose with the study amounts.

Sulfate, hydrochloride or "complex": does the form matter?

It might. NCCIH notes that glucosamine is sold as glucosamine sulfate or glucosamine hydrochloride, and that in its 2014 analysis of 25 glucosamine studies, people who used the prescription drug formulation generally had more favorable results. It adds that most of those studies had a high risk of bias, were more than 20 years old and were funded by the drug maker. So the pattern could reflect a real difference between products or it could reflect bias, and the agency does not resolve it.

For a shopper, this means two things. First, the form on the label should match what you think you are buying. NCCIH describes the US two-year trial as using glucosamine hydrochloride. Second, a "joint complex" that folds glucosamine into a long list of other ingredients does not inherit the results of any glucosamine trial. Each ingredient needs its own dose and its own evidence, and a proprietary blend removes both. We flag this in every review where a blend hides the amounts.

Are glucosamine and chondroitin safe?

NCCIH says no major safety problems have been identified in large studies of either one for osteoarthritis. It does flag two cautions. Glucosamine may raise blood glucose in some people, and both have been associated with a higher risk of bleeding in people who take the blood thinner warfarin. Little is known about their safety during pregnancy or breastfeeding.

Those cautions are why the doctor or pharmacist question is not optional if you have diabetes, take a blood thinner, or are pregnant. Bring the bottle and the exact label so they can see the amounts and every other ingredient.

Also remember that dietary supplements are not approved by the FDA before they are sold. The FDA states that under the 1994 DSHEA law it does not have the authority to approve dietary supplements before they are marketed, and that a firm generally does not have to give the agency its evidence of safety. Quality and accuracy of the label are largely the seller's responsibility.

A practical checklist before you buy a joint supplement

1. Find the printed milligram amount for glucosamine and chondroitin. If there is none, treat the dose as unknown.
2. Compare it with the amounts the trial used (1,500 mg and 1,200 mg a day in GAIT) and note whether a serving or the daily total is on the label.
3. Check the form: glucosamine sulfate versus hydrochloride, and chondroitin sulfate.
4. Ask which study the page cites, then check whether it tested that ingredient, that dose and that form.
5. Work out the monthly price for the full daily dose, not for one capsule. Bundle prices in our reviews are converted to a monthly figure.
6. Read the refund terms and keep the order email. See the ClickBank refund guide.
7. Talk to a doctor or pharmacist first if you take warfarin, have diabetes, or are pregnant.

You can browse every joint offer we have reviewed in the joints and mobility category.

FAQ

Do glucosamine and chondroitin work for knee osteoarthritis?

The evidence is inconsistent. NCCIH says it is still uncertain whether they help, and the 2019 ACR/Arthritis Foundation guideline recommends against them, while a 2021 orthopaedic guideline says they may help mild-to-moderate cases. Ask your doctor what fits your situation.

What dose of glucosamine was used in studies?

The GAIT trial used 1,500 mg of glucosamine and 1,200 mg of chondroitin sulfate per day for 24 weeks. Many labels list far less per serving, so read the amount and the number of servings a day.

Can I take glucosamine with a blood thinner?

NCCIH reports that glucosamine and chondroitin have been associated with a higher bleeding risk in people taking warfarin. Ask the prescriber or pharmacist before starting either.

How long does it take to see a result?

There is no reliable timeline. GAIT ran 24 weeks and the follow-up ran 24 months, and neither showed a statistically significant benefit in the overall group. Be wary of any page that promises a specific number of days.